We can’t show the full text here under this license. Use the link below to read it at the source.
Gut Microbiome in Alzheimer’s Disease: from Mice to Humans
Changes in Gut Bacteria Linked to Alzheimer's Disease in Mice and People
AI simplified
Abstract
Changes in the gut microbiome are associated with the accumulation of amyloid beta in Alzheimer's disease.
- Gut dysbiosis may influence the development and progression of Alzheimer's disease.
- Increased amyloid beta deposition is linked to alterations in gut microbiome composition.
- Cognitive impairment could be related to changes in the gut microbiome.
- Metabolites produced by the gut microbiome may play a role in Alzheimer's disease pathology.
- Potential therapies include antibiotics, prebiotics, probiotics, fecal microbiota transplantation, and dietary interventions.
AI simplified